|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/505 | (2006.01) |
| A61K 31/519 | (2006.01) | ||
| A61P 11/00 | (2006.01) | ||
| A61K 31/496 | (2006.01) |
| (11) | Number of the document | 3700529 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18785961.6 |
| Date of filing the European patent application | 2018-10-12 | |
| (97) | Date of publication of the European application | 2020-09-02 |
| (45) | Date of publication and mention of the grant of the patent | 2025-07-09 |
| (46) | Date of publication of the claims translation | 2025-10-10 |
| (86) | Number | PCT/EP2018/077952 |
| Date | 2018-10-12 |
| (87) | Number | WO 2019/081235 |
| Date | 2019-05-02 |
| (30) | Number | Date | Country code |
| 17197719 | 2017-10-23 | EP |
| (72) |
HERRMANN, Franziska, Elena , DE
NICKOLAUS, Peter , DE
WOLLIN, Stefan, Ludwig, Michael , DE
|
| (73) |
Boehringer Ingelheim International GmbH ,
Binger Strasse 173, 55216 Ingelheim am Rhein,
DE
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Naujas veikliųjų medžiagų derinys, skirtas progresuojančių fibrozinių intersticinių plaučių ligų (PF-ILD) gydymui |
| NEW COMBINATION OF ACTIVE AGENTS FOR THE TREATMENT OF PROGRESSIVE FIBROSING INTERSTITIAL LUNG DISEASES (PF-ILD) |
| Payment date | Validity (years) | Amount | |
| 2025-09-29 | 8 | 185.00 EUR |
| 2026-10-12 |